siRNA-mediated knock-down of ABCG2 expression lowered the self-renewal capacity of the cells and increased the efficiency of chemotherapy-induced apoptosis in colon adenocarcinoma cells and CD133-positive colorectal carcinoma cells. The gene discussed is ABCG2; the disease is colon adenocarcinoma.